The
Percutaneous Coronary Intervention Market size was valued at USD 7.98 Billion
in 2022 and is projected to grow from USD 8.78 Billion in 2023 to USD 20.53
Billion by 2032, exhibiting a compound annual growth rate (CAGR) of 8.86%
during the forecast period (2023 - 2032).
The
percutaneous
coronary intervention (PCI) market
continues to evolve with technological advancements and increasing prevalence
of coronary artery disease (CAD). With rising cases globally, demand for PCI
procedures and related devices remains robust. Innovations such as drug-eluting
stents, bioresorbable scaffolds, and advanced catheterization techniques
enhance patient outcomes and procedural efficacy. Key players focus on research
for safer and more effective devices, driving market growth. Moreover, a
growing aging population, sedentary lifestyles, and dietary habits contribute
to CAD incidence, expanding the market further. However, cost constraints,
regulatory challenges, and alternative treatments pose potential barriers.
Overall, the PCI market is poised for steady expansion amid dynamic healthcare
landscapes.
Percutaneous
Coronary Intervention (PCI), also known as percutaneous
coronary angioplasty or
percutaneous cardiac intervention, stands at the forefront of interventional
cardiology, revolutionizing the treatment of coronary artery disease (CAD). As
a minimally invasive procedure, PCI involves widening narrowed or obstructed
coronary arteries to restore blood flow to the heart muscle. This technique has
significantly transformed the management of CAD, offering patients a less
invasive alternative to traditional surgical approaches.
The
PCI market continues to witness substantial growth globally, driven by
advancements in technology, increasing prevalence of CAD, and rising demand for
minimally invasive procedures. With a focus on improving patient outcomes and
reducing recovery times, medical device manufacturers are investing heavily in
research and development to enhance PCI techniques and develop innovative
devices.
Key
players in the PCI market are leveraging cutting-edge technologies such as
drug-eluting stents, bioresorbable scaffolds, and advanced imaging modalities
to enhance procedural efficacy and patient safety. Additionally, the
integration of robotics and artificial intelligence is poised to further
revolutionize PCI procedures, enabling greater precision and efficiency.
As
healthcare systems worldwide prioritize the adoption of minimally invasive
techniques, the PCI market is anticipated to experience sustained growth in the
coming years. With a growing aging population and increasing prevalence of CAD
risk factors such as obesity and diabetes, the demand for PCI procedures is
expected to remain robust, driving market expansion and innovation in the field
of interventional cardiology.
Market
Segmentation
The
MRFR report provides a complete segmental analysis of the percutaneous coronary
intervention market report based on end user as well as product type.
Based
on product type, the percutaneous coronary intervention market share is
segmented into accessories, coronary guidewire, PTCA catheters, and coronary
stents. Of these, the coronary stents segment will have the largest share in
the market over the forecast period. This is chiefly due to the introduction of
new products in this market.
Based
on end user, the percutaneous coronary intervention market is segmented into
research & academic institutes, ambulatory surgical centers, hospitals and
specialty clinics, and others. Of these, the hospitals and specialty clinics
segment will dominate the market over the forecast period. This is due to the
higher availability of experts required for performing the procedure coupled
with a higher footfall of patients in hospitals.
Regional
Analysis
By
region, the percutaneous coronary intervention market share report covers the
latest trends and growth opportunities across Europe, the Asia Pacific (APAC),
the Americas, and the Middle East and Africa (MEA). Of these, the Americas is
expected to dominate the market during the forecast period due to the
increasing acceptability of percutaneous coronary intervention methods and
growing awareness.
Europe
is projected to have the second-largest share in the market during the forecast
period. This is owing to the growing number of hospitalizations for
percutaneous coronary intervention methods such as cerebral angioplasty and
carotid artery angioplasty.
Key
Players
The
percutaneous
coronary intervention companies
are Terumo Corporation (Japan), Merit Medical System (Utah), Meril Lifesciences
Pvt. Ltd (India), Medtronic PLC (US), Cordis (US), Cook (US), Comed BV
(Netherlands), C. R. Bard, Inc. (US), Boston Scientific Corporation (US),
BIOTRONIK (US), Biosensors International Group, Ltd (Singapore), B. Braun
Melsungen AG (UK), ASAHI INTECC Company Limited (Japan), and Abbott (US), among
others. Key players are adopting different strategies to create a niche in the
market, such as research and development, joint ventures, mergers and
acquisitions, partnerships, product innovations and launches, collaborations,
and more.
Related Reports:
Type-1 Diabetes Treatment
Metal Implants and Medical Alloys
Nasal Drug Delivery
Stoma or Ostomy Care
Pompe Disease Treatment
For More Information, Please
Visit @ Market Research Future
Comments
Post a Comment